New malaria drug tested in children to stop relapses
NCT ID NCT07052162
Summary
This study is testing a drug called tafenoquine in children in Papua New Guinea to see if it can safely and effectively treat a type of malaria called vivax malaria. Vivax malaria is tricky because it can hide in the liver and cause people to get sick again months later. The study will see how children's bodies process the drug, check for side effects, and see if taking it with food changes how well it works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS OF TAFENOQUINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alexishafen Health Centre
RECRUITINGMadang, Madang Province, MP511, Papua New Guinea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.